1 Product identity
Ingredient risk
Contains a high-risk ingredient
Choline with Inositol and PABA
BrandBronson→Other Combinations Tablet or Pill 15 ingredients 1 high-risk 1 caution DSLD #25051Net contents: 100 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-08-23
2 Ingredients (15)
IngredientGroupSafety
Para-Aminobenzoic AcidPABA—
CelluloseCellulose—
Stearic AcidStearic Acid—
MaltodextrinMaltodextrin—
Polyethylene GlycolPolyethylene glycol—
Lecithinlecithin—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⛔ High-risk ingredient — documented serious harm
Inositol — GDM prevention — 4 g/day from first trimester in high-risk women [2]
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Choline — Generally Safe
⚠ Fishy odor at high doses
Inositol — High risk
⚠ GI disturbance at high doses (>12 g)
⚠ May lower blood glucose
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
Silicon — Generally Safe
⚠ Very low toxicity
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
4 Label claims
• All Other
5 Data source
DSLD ID25051
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-08-23
6 More from Bronson
View Bronson Safety Scorecard → 104 products
30 Day Beauty Regimen5-HTP 200 mgAlpha Lipoic Acid with C and EAmino Acid ComplexAntarctic Krill Oil 2000 mgAstaxanthin 4 mg7 Cite this page
Vancouver
Pkhakadze G. Choline with Inositol and PABA — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Oct 19]. Available from: https://supplement.ge/products/choline-with-inositol-and-paba-25051/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG